L. Cals
- Oncology top 5%
- Cancer Treatment and Pharmacology 15
- Colorectal Cancer Treatments and Studies 8
- Colorectal Cancer Screening and Detection 6
- HER2/EGFR in Cancer Research 4
- Global Cancer Incidence and Screening 4
- Otorhinolaryngology top 5%
- Head and Neck Cancer Studies 6
- Hepatology top 10%
-
- Lung Cancer Treatments and Mutations 7
-
- Breast Cancer Treatment Studies 11
- Co-authors
- Xavier PivotJean‐Luc RaoulCatherine BrézaultJean‐Luc Van LaethemMarc PeetersL. ChaigneauFernando BazánJean-Claude Vedovato
- Partner nations
- FranceBelgiumUnited States
In The Last Decade
L. Cals
40 papers receiving 651 citations
Peers
Comparison fields: 5 of 80
- Oncology 495
- Otorhinolaryngology 63
- Hepatology 80
- Pulmonary and Respiratory Medicine 253
- Cancer Research 102
Countries citing papers authored by L. Cals
This map shows the geographic impact of L. Cals's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by L. Cals with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites L. Cals more than expected).
Fields of papers citing papers by L. Cals
This network shows the impact of papers produced by L. Cals. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by L. Cals. The network helps show where L. Cals may publish in the future.
Co-authorship network
The 25 scholars most cited alongside L. Cals, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 3 | |
| 2 | 2014 | 6 | |
| 3 | 2013 | 73 | |
| 4 | 2013 | 8 | |
| 5 | 2013 | 9 | |
| 6 | 2012 | 23 | |
| 7 | 2012 | 14 | |
| 8 | 2012 | 14 | |
| 9 | 2011 | 9 | |
| 10 | 2011 | 41 | |
| 11 | 2009 | 7 | |
| 12 | 2009 | 41 | |
| 13 | 2008 | 19 | |
| 14 | 2007 | 30 | |
| 15 | Cetuximab in combination with irinotecan/5-fluorouracil (5-FU)/folinic acid (FA) (FOLFIRI) in the first-line treatment of metastatic colorectal cancer (mCRC) | 2005 | 17 |
| 16 | 2004 | 23 | |
| 17 | 2004 | 6 | |
| 18 | 2001 | 67 | |
| 19 | 2000 | 33 | |
| 20 | 1997 | 20 |
About L. Cals
L. Cals is a scholar working on Otorhinolaryngology, Oncology and Cancer Research, having authored 41 papers that have together received 674 indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (15 papers), Breast Cancer Treatment Studies (11 papers), Colorectal Cancer Treatments and Studies (8 papers), Lung Cancer Treatments and Mutations (7 papers), Colorectal Cancer Screening and Detection (6 papers), Head and Neck Cancer Studies (6 papers), HER2/EGFR in Cancer Research (4 papers) and Global Cancer Incidence and Screening (4 papers). The work is most often cited by research in Oncology (495 citations), Otorhinolaryngology (63 citations) and Hepatology (80 citations). L. Cals has collaborated with scholars based in France, Belgium and United States. Frequent co-authors include Xavier Pivot, Jean‐Luc Raoul, Catherine Brézault, Jean‐Luc Van Laethem, Marc Peeters, L. Chaigneau, Fernando Bazán, Jean-Claude Vedovato, Cristian Villanueva and M. Mueser. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, BMC Cancer, The Breast and Critical Reviews in Oncology/Hematology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.